Eugene Shenderov


If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Eugene Shenderov is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Immunologic Cytotoxicity Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
T-Cell Antigen Receptor Medicine & Life Sciences
Protein Binding Medicine & Life Sciences
Peptide Library Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Peptides Medicine & Life Sciences
Peptide Fragments Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

Acute Promyelocytic Leukemia

Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype

Shenderov, E., Isaacsson Velho, P., Awan, A. H., Wang, H., Mirkheshti, N., Lotan, T. L., Carducci, M. A., Pardoll, D. M., Eisenberger, M. A. & Antonarakis, E. S., Jan 1 2019, In : Prostate. 79, 13, p. 1572-1579 8 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Prostate-Specific Antigen

Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations

Antonarakis, E. S., Shaukat, F., Isaacsson Velho, P., Kaur, H., Shenderov, E., Pardoll, D. M. & Lotan, T. L., Jan 1 2018, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Prostatic Neoplasms
Disease-Free Survival
Carcinoid Tumor
Prostatic Neoplasms
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
human glutamate carboxypeptidase II

Resistance is futile: Engineering the Adoptive T-Cell therapies of the future

Shenderov, E. & Ambinder, R. F., Apr 10 2018, In : Journal of Clinical Oncology. 36, 11, p. 1140-1142 3 p.

Research output: Contribution to journalShort survey

Cell- and Tissue-Based Therapy